| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/30/2004 | US6713294 New cytosine-glycosylases, and their use for mutagenesis, for nucleic acid modification and cell killing |
| 03/30/2004 | US6713291 Method of immunotherapy; obtain electrodes, obtain waveform generator, generate electrically conductive pathways between electrodes and generator, incubate with transfer particles, transfer particles into cells with electrical pulse |
| 03/30/2004 | US6713288 Converts 5-monosubstituted hydantoins to l- or d-amino acids for the production of enantiomerically enriched amino acids |
| 03/30/2004 | US6713285 Generating preferential mutation in nucleotide squences; obtain nucleotide sequences sample, incubate with reaction mixture and mutagenic primers, amplify nucleotide sequences, recover and detect mutation in nucleotide sequences |
| 03/30/2004 | US6713283 Tyrosylprotein sulfotransferases |
| 03/30/2004 | US6713282 End selection in directed evolution |
| 03/30/2004 | US6713281 Directed evolution of thermophilic enzymes |
| 03/30/2004 | US6713279 Targeting of a genetic vaccine to a particular tissue or cell type of interest by creating a library of mutant polypeptides and screening them against cell of interest |
| 03/30/2004 | US6713278 Isolated baculovirus viral particles obtained by a method of producing a recombinant membrane receptor protein by culturing an insect cell transfected with a baculovirus expression vector |
| 03/30/2004 | US6713277 Expression of nucleic acid molecule of invention suppresses obesity |
| 03/30/2004 | US6713276 Modulation of Aβ levels by β-secretase BACE2 |
| 03/30/2004 | US6713273 Monitoring therapeutic levels of s-adenosylmethionine in fluid sample; obtain sample containing enzymatic polypeptides and glycine, measure concentration of preferential reaction products compare to s-adenosylmethionine |
| 03/30/2004 | US6713270 Dna encoding a novel steroid receptor is introduced into cell with reporter gene, potential ligand is incubated with cell, production of reporter protein means ligand binds receptor |
| 03/30/2004 | US6713266 Immunoassay method for measuring a cyclosporine and its metabolites |
| 03/30/2004 | US6713263 Method for mapping a nucleic acid |
| 03/30/2004 | US6713261 Compound is brought into contact with cell overexpressing a bcl2 proto-oncogene and/or a bcl2- related anti-apoptotic protein, and positive genotoxic effects of said compound on said cell are observed |
| 03/30/2004 | US6713259 Nucleotide sequences coding insecticidal protein for use in biologiical pest control |
| 03/30/2004 | US6713254 DNA probes, method and kit for identifying antibiotic-resistant strains of bacteria |
| 03/30/2004 | US6713248 Methods for detection of gamma-secretase activity and identification of inhibitors thereof |
| 03/30/2004 | US6713247 Human CNS cell lines and methods of use therefor |
| 03/30/2004 | US6713117 Vegetable oil having elevated stearic acid content |
| 03/30/2004 | US6713072 Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
| 03/30/2004 | US6713070 Viral particles which are released after the infection with the human cytomegalovirus, and the use of said particles as a vaccine |
| 03/30/2004 | US6713067 Which: (i) lacks a functional vhs gene, or a functional equivalent thereof; and (ii) comprises a functional ul43 gene, or a functional equivalent thereof such that dendritic cells are infected with said virus. |
| 03/30/2004 | US6713065 Methods of using hedgehog proteins to modulate hematopoiesis and vascular growth |
| 03/30/2004 | US6713064 Immune enhancing agent for treating HIV infected humans |
| 03/30/2004 | US6713063 Insecticides |
| 03/30/2004 | US6712612 Transfecting particles with simian immunodeficiency virus (siv) transfer vector; gene expression; side effect reduction |
| 03/30/2004 | CA2439841A1 A method for producing a multi-gene recombinant vector construct and the application |
| 03/30/2004 | CA2411512A1 Compounds and methods for modulating bacterial functions |
| 03/30/2004 | CA2411508A1 Methods for polysaccharide adhesin synthesis modulation |
| 03/30/2004 | CA2311182C Transcription factor decoy and tumor growth inhibitor |
| 03/30/2004 | CA2277165C Purification and/or concentration of dna by cross-flow filtration, separation of endotoxins from a nucleic acid preparation |
| 03/30/2004 | CA2263443C Process for determining the status of an organism by peptide measurement |
| 03/30/2004 | CA2235471C Dna encoding a plasminogen activating protein |
| 03/30/2004 | CA2137824C Yeast strains expressing the lactic ldh gene, and vectors which can be used for obtaining said strains |
| 03/30/2004 | CA2124797C Hiv probes for use in solution phase sandwich hybridization assays |
| 03/25/2004 | WO2004025416A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | WO2004025264A2 Rapidly degraded reporter fusion proteins |
| 03/25/2004 | WO2004025263A2 Protein and peptide expression for passive immunity |
| 03/25/2004 | WO2004025256A2 Viral deconstruction through capsid assembly in vitro |
| 03/25/2004 | WO2004025128A1 Liquid delivery device |
| 03/25/2004 | WO2004024958A1 Nucleic-acid ink compositions for arraying onto a solid support |
| 03/25/2004 | WO2004024955A1 Bio-chip prepared by gelation on a chip substrate |
| 03/25/2004 | WO2004024954A1 Method for screening of a lipase having improved enzymatic activity using yeast surface display vector and the lipase |
| 03/25/2004 | WO2004024953A1 Method for preparation of cdna tags for identifying expressed genes and method for analysis of gene expression |
| 03/25/2004 | WO2004024952A1 Method of diagnosing ovarian endometriosis |
| 03/25/2004 | WO2004024950A1 Method for the selection of nucleic acid ligands |
| 03/25/2004 | WO2004024947A1 Actn3 genotype screen for athletic performance |
| 03/25/2004 | WO2004024941A2 Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
| 03/25/2004 | WO2004024940A2 Rna-mediated gene modulation |
| 03/25/2004 | WO2004024936A2 Mutant forms of glutamate receptors mglur2 and mglur3 |
| 03/25/2004 | WO2004024933A2 Method for zymotic production of fine chemicals (mety) containing sulphur |
| 03/25/2004 | WO2004024932A2 Method for zymotic production of fine chemicals (meta) containing sulphur |
| 03/25/2004 | WO2004024931A2 Method for the production by fermentation of sulphur-containing fine chemicals (metf) |
| 03/25/2004 | WO2004024929A2 Proximity-aided synthesis of templated molecules |
| 03/25/2004 | WO2004024928A2 Transformed plants with enhanced prenylquinone biosynthesis |
| 03/25/2004 | WO2004024927A1 Protein production method |
| 03/25/2004 | WO2004024926A2 Transgenic expression cassettes for expressing nucleic acid sequences in sink tissues of plants that store carbohydrate |
| 03/25/2004 | WO2004024925A2 Collectin-complement activating protein chimeras |
| 03/25/2004 | WO2004024924A1 Glutathione s transferase localized in sieve tube |
| 03/25/2004 | WO2004024923A1 Novel glycerol kinase, gene thereof and process for producing the glycerol kinase by using the gene |
| 03/25/2004 | WO2004024922A1 Aspartyl protease inhibitor as a nematode allergen |
| 03/25/2004 | WO2004024921A1 Human antihuman mcp-1 antibody and antibody fragment thereof |
| 03/25/2004 | WO2004024920A1 Preventives/remedies for neurodegenerative diseases |
| 03/25/2004 | WO2004024919A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | WO2004024918A1 In vitro evolution of enzyme specificity |
| 03/25/2004 | WO2004024917A2 Single-molecule in vitro evolution |
| 03/25/2004 | WO2004024916A1 Recombination process for recombining fragments of variant polynucleotides |
| 03/25/2004 | WO2004024915A1 Gene expression system based on codon translation efficiency |
| 03/25/2004 | WO2004024912A1 Transglutaminase-producing strain |
| 03/25/2004 | WO2004024911A1 Enhancers specific to motor nerve cells/sensory nerve cells |
| 03/25/2004 | WO2004024910A1 Particle for magnetically induced membrane transport |
| 03/25/2004 | WO2004024909A2 Recombinant colstridium neurotoxin fragments |
| 03/25/2004 | WO2004024906A1 Nucleoside triphosphate diphosphohydrolase (ntpdase 8) and uses thereof |
| 03/25/2004 | WO2004024905A1 Recombinant human herpes simplex virus for producing lentivirus vectors |
| 03/25/2004 | WO2004024904A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | WO2004024898A2 Nematode fatty acid desaturase-like sequences |
| 03/25/2004 | WO2004024886A2 Microarray synthesis and assembly of gene-length polynucleotides |
| 03/25/2004 | WO2004024884A2 Syts as modifiers of the p21 pathway and methods of use |
| 03/25/2004 | WO2004024883A2 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE |
| 03/25/2004 | WO2004024882A2 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 03/25/2004 | WO2004024880A2 AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 03/25/2004 | WO2004024879A2 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 03/25/2004 | WO2004024876A2 Polyhydroxyalkanoate production by coenzyme a-dependent aldehyde dehydrogenase pathways |
| 03/25/2004 | WO2004024875A2 Mammalian megakaryocyte progenitor cell |
| 03/25/2004 | WO2004024872A2 Method for expression of small antiviral rna molecules within a cell |
| 03/25/2004 | WO2004024871A2 Antibodies and methods for generating genetically altered antibodies with high affinity |
| 03/25/2004 | WO2004024870A2 Construction of bacillus licheniformis t1 strain and fermentation production of crude enzyme extract therefrom |
| 03/25/2004 | WO2004024867A2 Vigilant vector system |
| 03/25/2004 | WO2004024864A2 Rna-cleaving dna enzymes with altered regio- or enantioselectivity |
| 03/25/2004 | WO2004024863A2 Adenoviral va1 pol iii expression system for rna expression |
| 03/25/2004 | WO2004024862A2 Yeast protein expression secretion system |
| 03/25/2004 | WO2004024789A1 Phenolic polymer nanotube and process for producing the same |
| 03/25/2004 | WO2004024777A1 Hydroxyalkyl starch derivatives |
| 03/25/2004 | WO2004024776A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | WO2004024771A1 Human cd3-specific antibody with immunosuppressive properties |
| 03/25/2004 | WO2004024769A2 Ostertagia vaccine |
| 03/25/2004 | WO2004024766A1 Kdr peptides and vaccines containing the same |
| 03/25/2004 | WO2004024764A1 Pharmaceutical composition and medical treatments comprising notch ligand proteins |